{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:08:26Z","timestamp":1791389306941,"version":"4.3.3"},"reference-count":107,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013671","name":"Sun Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013671","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Photodiagnosis and Photodynamic Therapy"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.pdpdt.2025.104649","type":"journal-article","created":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T02:32:11Z","timestamp":1748053931000},"page":"104649","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["5-aminolevulinic acid photodynamic therapy for the treatment of basal and squamous cell carcinoma: A systematic review"],"prefix":"10.1016","volume":"54","author":[{"given":"Nathalie C.","family":"Zeitouni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Schlesinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenal","family":"Kheterpal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puneet S.","family":"Jolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared","family":"Jagdeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pdpdt.2025.104649_bib0001","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jdin.2020.10.013","article-title":"The global burden of skin cancer: a longitudinal analysis from the Global Burden of Disease Study, 1990-2017","volume":"2","author":"Urban","year":"2021","journal-title":"JAAD Int."},{"issue":"2","key":"10.1016\/j.pdpdt.2025.104649_bib0002","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jaad.2021.03.109","article-title":"United States burden of melanoma and non-melanoma skin cancer from 1990 to 2019","volume":"85","author":"Aggarwal","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"issue":"2","key":"10.1016\/j.pdpdt.2025.104649_bib0003","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jaad.2018.03.060","article-title":"Basal cell carcinoma: epidemiology; pathophysiology; clinical and histological subtypes; and disease associations","volume":"80","author":"Cameron","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"issue":"1","key":"10.1016\/j.pdpdt.2025.104649_bib0004","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1046\/j.1365-2133.2002.04804.x","article-title":"Variations of basal cell carcinomas according to gender, age, location and histopathological subtype","volume":"147","author":"Scrivener","year":"2002","journal-title":"Br. J. Dermatol."},{"issue":"3","key":"10.1016\/j.pdpdt.2025.104649_bib0005","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1365-4362.1995.tb01561.x","article-title":"Age and site prevalence OE histologic subtypes OE basal cell carcinomas","volume":"34","author":"Betti","year":"1995","journal-title":"Int. J. Dermatol."},{"issue":"6","key":"10.1016\/j.pdpdt.2025.104649_bib0006","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1046\/j.1523-1747.1998.00217.x","article-title":"Differences in age, site distribution, and sex between nodular and superficial basal cell carcinoma indicate different types of tumors","volume":"110","author":"Bastiaens","year":"1998","journal-title":"J. Investig. Dermatol."},{"issue":"1","key":"10.1016\/j.pdpdt.2025.104649_bib0007","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1038\/s41598-021-83502-8","article-title":"The incidence and clinical analysis of non-melanoma skin cancer","volume":"11","author":"Ciazynska","year":"2021","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.pdpdt.2025.104649_bib0008","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1684\/ejd.2015.2546","article-title":"The incidence of metastatic basal cell carcinoma (mBCC) in Denmark, 1997-2010","volume":"25","author":"Nguyen-Nielsen","year":"2015","journal-title":"Eur. J. Dermatol."},{"issue":"3","key":"10.1016\/j.pdpdt.2025.104649_bib0009","doi-asserted-by":"crossref","first-page":"263","DOI":"10.4103\/amit.amit_83_24","article-title":"A case series analysis of basal cell carcinoma (BCC): not the deadliest but certainly the most destructive form of skin cancer","volume":"11","author":"Sharma","year":"2024","journal-title":"Acta Med. Int."},{"issue":"7","key":"10.1016\/j.pdpdt.2025.104649_bib0010","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/jso.23155","article-title":"The incidence of metastasis from cutaneous squamous cell carcinoma and the impact of its risk factors","volume":"106","author":"Brougham","year":"2012","journal-title":"J. Surg. Oncol."},{"issue":"5","key":"10.1016\/j.pdpdt.2025.104649_bib0011","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1001\/jamadermatol.2013.2139","article-title":"Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single-institution cohort study","volume":"149","author":"Schmults","year":"2013","journal-title":"JAMA Dermatol."},{"issue":"16","key":"10.1016\/j.pdpdt.2025.104649_bib0012","doi-asserted-by":"crossref","DOI":"10.2340\/00015555-3628","article-title":"Risk factors and prognosis for metastatic cutaneous squamous cell carcinoma: a cohort study","volume":"100","author":"Knuutila","year":"2020","journal-title":"Acta Derm. Venereol."},{"issue":"7","key":"10.1016\/j.pdpdt.2025.104649_bib0013","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2340\/00015555-3174","article-title":"Successful treatment for extensive Bowen\u2019s disease using daylight-mediated photodynamic therapy","volume":"99","author":"Safar","year":"2019","journal-title":"Acta Derm. Venereol."},{"issue":"3","key":"10.1016\/j.pdpdt.2025.104649_bib0014","first-page":"205","article-title":"Economic burden of skin cancer treatment in the USA: an analysis of the Medical Expenditure Panel Survey Data, 2012-2018","volume":"34","author":"Kao","year":"2023","journal-title":"Cancer Causes Control"},{"issue":"10","key":"10.1016\/j.pdpdt.2025.104649_bib0015","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1001\/jamadermatol.2014.762","article-title":"Incidence of nonmelanoma skin cancer in relation to ambient UV radiation in white populations, 1978-2012: empirical relationships","volume":"150","author":"Xiang","year":"2014","journal-title":"JAMA Dermatol."},{"issue":"9","key":"10.1016\/j.pdpdt.2025.104649_bib0016","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1016\/j.jid.2017.04.020","article-title":"Incidence, mortality, and trends of nonmelanoma skin cancer in Germany","volume":"137","author":"Leiter","year":"2017","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.pdpdt.2025.104649_bib0017","series-title":"EFUDEX\u24c7 (Fluorouracil) Topical Solutions and Cream. Full Prescribing Information","year":"2021"},{"key":"10.1016\/j.pdpdt.2025.104649_bib0018","series-title":"ALDARA\u24c7 (Imiquimod) Cream, 5%. Full Prescribing Information","year":"2018"},{"issue":"6","key":"10.1016\/j.pdpdt.2025.104649_bib0019","doi-asserted-by":"crossref","first-page":"611","DOI":"10.36849\/JDD.2020.4772","article-title":"Improving the appearance of surgical facial scars with incobotulinumtoxinA and microneedling","volume":"19","author":"Casabona","year":"2020","journal-title":"J. Drugs Dermatol."},{"issue":"1","key":"10.1016\/j.pdpdt.2025.104649_bib0020","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.prro.2019.10.014","article-title":"Definitive and postoperative radiation therapy for basal and squamous cell cancers of the skin: executive summary of an American Society for Radiation Oncology Clinical Practice Guideline","volume":"10","author":"Likhacheva","year":"2020","journal-title":"Pract. Radiat. Oncol."},{"issue":"2","key":"10.1016\/j.pdpdt.2025.104649_bib0021","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ijrobp.2019.02.024","article-title":"Pravastatin reverses established radiation-induced cutaneous and subcutaneous fibrosis in patients with head and neck cancer: results of the biology-driven phase 2 clinical trial Pravacur","volume":"104","author":"Bourgier","year":"2019","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"8","key":"10.1016\/j.pdpdt.2025.104649_bib0022","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1001\/archderm.136.8.1007","article-title":"Therapeutic ionizing radiation and the incidence of basal cell carcinoma and squamous cell carcinoma. The New Hampshire Skin Cancer Study Group","volume":"136","author":"Lichter","year":"2000","journal-title":"Arch. Dermatol."},{"issue":"11","key":"10.1016\/j.pdpdt.2025.104649_bib0023","article-title":"Cryosurgery for basal cell skin cancer of the head: 15 years of experience","volume":"13","author":"Pustinsky","year":"2023","journal-title":"Life (Basel)"},{"issue":"2","key":"10.1016\/j.pdpdt.2025.104649_bib0024","first-page":"161","article-title":"Diagnosis and treatment of basal cell and squamous cell carcinoma","volume":"86","author":"Firnhaber","year":"2012","journal-title":"Am. Fam. Physician"},{"issue":"12","key":"10.1016\/j.pdpdt.2025.104649_bib0025","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1001\/archdermatol.2009.291","article-title":"Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review","volume":"145","author":"Love","year":"2009","journal-title":"Arch. Dermatol."},{"issue":"3","key":"10.1016\/j.pdpdt.2025.104649_bib0026","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jaad.2017.10.006","article-title":"Guidelines of care for the management of basal cell carcinoma","volume":"78","author":"Kim","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"issue":"3","key":"10.1016\/j.pdpdt.2025.104649_bib0027","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jaad.2017.10.007","article-title":"Guidelines of care for the management of cutaneous squamous cell carcinoma","volume":"78","author":"Kim","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"issue":"2","key":"10.1016\/j.pdpdt.2025.104649_bib0028","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/bjd\/ljac042","article-title":"British Association of Dermatologists guidelines for the management of people with cutaneous squamous cell carcinoma in situ (Bowen disease) 2022","volume":"188","author":"Sharma","year":"2023","journal-title":"Br. J. Dermatol."},{"issue":"10","key":"10.1016\/j.pdpdt.2025.104649_bib0029","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3390\/cancers8100090","article-title":"Photodynamic therapy for non-melanoma skin cancers","volume":"8","author":"Cohen","year":"2016","journal-title":"Cancers"},{"issue":"22","key":"10.1016\/j.pdpdt.2025.104649_bib0030","doi-asserted-by":"crossref","first-page":"5398","DOI":"10.3390\/molecules25225398","article-title":"Photodynamic therapy for basal cell carcinoma: the clinical context for future research priorities","volume":"25","author":"Collier","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.pdpdt.2025.104649_bib0031","series-title":"LEVULAN\u24c7 KERASTICK\u24c7 (Aminolevulinic Acid HCl) For Topical Solution, 20%. Full Prescribing Information","year":"2024"},{"issue":"2","key":"10.1016\/j.pdpdt.2025.104649_bib0032","first-page":"19","article-title":"In-office painless aminolevulinic acid photodynamic therapy: a proof of concept study and clinical experience in more than 100 patients","volume":"9","author":"Martin","year":"2016","journal-title":"J. Clin. Aesthet. Dermatol."},{"issue":"4","key":"10.1016\/j.pdpdt.2025.104649_bib0033","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jaad.2019.09.010","article-title":"A regimen to minimize pain during blue light photodynamic therapy of actinic keratoses: bilaterally controlled, randomized trial of simultaneous versus conventional illumination","volume":"82","author":"Kaw","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"issue":"2","key":"10.1016\/j.pdpdt.2025.104649_bib0034","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jaad.2023.03.056","article-title":"Comparative effectiveness of 5-aminolevulinic acid photodynamic therapy with no incubation versus one-hour incubation for the treatment of actinic keratosis: a randomized controlled trial","volume":"89","author":"Anvery","year":"2023","journal-title":"J. Am. Acad. Dermatol."},{"issue":"4","key":"10.1016\/j.pdpdt.2025.104649_bib0035","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1046\/j.1365-2133.2002.04719.x","article-title":"Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group","volume":"146","author":"Morton","year":"2002","journal-title":"Br. J. Dermatol."},{"issue":"4","key":"10.1016\/j.pdpdt.2025.104649_bib0036","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1751-1097.1998.tb05228.x","article-title":"The effect of fluence rate on tumor and normal tissue responses to photodynamic therapy","volume":"67","author":"Sitnik","year":"1998","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.pdpdt.2025.104649_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2022.103260","article-title":"Effective fluence and dose at skin depth of daylight and lamp sources for PpIX-based photodynamic therapy","volume":"41","author":"Ruiz","year":"2023","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"10.1016\/j.pdpdt.2025.104649_bib0038","series-title":"AMELUZ\u24c7 (Aminolevulinic Acid Hydrochloride) Topical Gel. Full Prescribing Information","year":"2024"},{"issue":"2","key":"10.1016\/j.pdpdt.2025.104649_bib0039","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1751-1097.1985.tb01554.x","article-title":"In vivo and post mortem measurements of the attenuation spectra of light in mammalian tissues","volume":"42","author":"Wilson","year":"1985","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.pdpdt.2025.104649_bib0040","series-title":"AMELUZ\u24c7 (5-Aminolevulinic Acid Hydrochloride) 78 Mg\/G Gel. Summary of Product Characteristics","year":"2021"},{"key":"10.1016\/j.pdpdt.2025.104649_bib0041","series-title":"METVIX\u24c7 (Methylaminolevulinic Acid Hydrochloride) 160 Mg\/G Cream. Summary of Product Characteristics","year":"2022"},{"issue":"4","key":"10.1016\/j.pdpdt.2025.104649_bib0042","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/bjd.17309","article-title":"British Association of Dermatologists and British Photodermatology Group guidelines for topical photodynamic therapy 2018","volume":"180","author":"Wong","year":"2019","journal-title":"Br. J. Dermatol."},{"issue":"8","key":"10.1016\/j.pdpdt.2025.104649_bib0043","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/j.1468-3083.2010.03877.x","article-title":"Photodynamic therapy for basal cell carcinoma: clinical and pathological determinants of response","volume":"25","author":"Fantini","year":"2011","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"7","key":"10.1016\/j.pdpdt.2025.104649_bib0044","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"issue":"4","key":"10.1016\/j.pdpdt.2025.104649_bib0045","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jclinepi.2010.09.011","article-title":"GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology","volume":"64","author":"Guyatt","year":"2011","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.pdpdt.2025.104649_bib0046","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/2046-4053-3-82","article-title":"A checklist designed to aid consistency and reproducibility of GRADE assessments: development and pilot validation","volume":"3","author":"Meader","year":"2014","journal-title":"Syst. Rev."},{"key":"10.1016\/j.pdpdt.2025.104649_bib0047","series-title":"How to GRADE the Quality of the Evidence","author":"Ryan","year":"2024"},{"issue":"5","key":"10.1016\/j.pdpdt.2025.104649_bib0048","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/bjd.15967","article-title":"Treatment of superficial basal cell carcinoma by topical photodynamic therapy with fractionated 5-aminolaevulinic acid 20% vs. two-stage topical methyl aminolaevulinate: results of a randomized controlled trial","volume":"178","author":"Kessels","year":"2018","journal-title":"Br. J. Dermatol."},{"issue":"6","key":"10.1016\/j.pdpdt.2025.104649_bib0049","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2340\/00015555-1448","article-title":"Light fractionation significantly improves the response of superficial basal cell carcinoma to aminolaevulinic acid photodynamic therapy: five-year follow-up of a randomized, prospective trial","volume":"92","author":"de Vijlder","year":"2012","journal-title":"Acta Derm. Venereol."},{"issue":"12","key":"10.1016\/j.pdpdt.2025.104649_bib0050","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1038\/sj.jid.5700460","article-title":"Fractionated illumination significantly improves the response of superficial basal cell carcinoma to aminolevulinic acid photodynamic therapy","volume":"126","author":"de Haas","year":"2006","journal-title":"J. Investig. Dermatol."},{"issue":"4","key":"10.1016\/j.pdpdt.2025.104649_bib0051","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/j.1365-2133.2008.08787.x","article-title":"Fractionated 5-aminolaevulinic acid-photodynamic therapy vs. surgical excision in the treatment of nodular basal cell carcinoma: results of a randomized controlled trial","volume":"159","author":"Mosterd","year":"2008","journal-title":"Br. J. Dermatol."},{"issue":"2","key":"10.1016\/j.pdpdt.2025.104649_bib0052","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jaad.2013.02.014","article-title":"Fractionated 5-aminolevulinic acid photodynamic therapy after partial debulking versus surgical excision for nodular basal cell carcinoma: a randomized controlled trial with at least 5-year follow-up","volume":"69","author":"Roozeboom","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"issue":"8","key":"10.1016\/j.pdpdt.2025.104649_bib0053","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/j.1468-3083.2012.04619.x","article-title":"Photodynamic therapy using topical 5-aminolaevulinic acid vs. surgery for basal cell carcinoma","volume":"27","author":"Cosgarea","year":"2013","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"4","key":"10.1016\/j.pdpdt.2025.104649_bib0054","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1046\/j.1365-2133.2001.04141.x","article-title":"Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial","volume":"144","author":"Wang","year":"2001","journal-title":"Br. J. Dermatol."},{"issue":"6","key":"10.1016\/j.pdpdt.2025.104649_bib0055","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1562\/0031-8655(2000)071<0724:PTOSBC>2.0.CO;2","article-title":"Photodynamic therapy of superficial basal cell carcinoma with 5-aminolevulinic acid with dimethylsulfoxide and ethylendiaminetetraacetic acid: a comparison of two light sources","volume":"71","author":"Soler","year":"2000","journal-title":"Photochem. Photobiol."},{"issue":"3","key":"10.1016\/j.pdpdt.2025.104649_bib0056","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1046\/j.1365-2133.2001.04085.x","article-title":"Bowen's disease, solar keratoses and superficial basal cell carcinomas treated by photodynamic therapy using a large-field incoherent light source","volume":"144","author":"Varma","year":"2001","journal-title":"Br. J. Dermatol."},{"issue":"3","key":"10.1016\/j.pdpdt.2025.104649_bib0057","first-page":"157","article-title":"Recurrence rate of basal cell carcinoma after topical aminolevulinic acid-based photodynamic therapy","volume":"12","author":"Naidenov","year":"2004","journal-title":"Acta Dermatovenerol. Croat."},{"issue":"1","key":"10.1016\/j.pdpdt.2025.104649_bib0058","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14558","article-title":"Treatment of superficial basal cell carcinoma with 7.8% 5-aminolaevulinic acid nanoemulsion-based gel (BF-200 ALA) and photodynamic therapy: results in clinical practice in a tertiary hospital","volume":"34","author":"Navarro-Trivi\u00f1o","year":"2021","journal-title":"Dermatol. Ther."},{"issue":"3","key":"10.1016\/j.pdpdt.2025.104649_bib0059","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1034\/j.1600-0781.2003.00024.x","article-title":"Topical 5-aminolaevulinic acid photodynamic therapy for cutaneous lesions: outcome and comparison of light sources","volume":"19","author":"Clark","year":"2003","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"issue":"3\u20134","key":"10.1016\/j.pdpdt.2025.104649_bib0060","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.pdpdt.2009.09.001","article-title":"Long-term follow-up of topical 5-aminolaevulinic acid photodynamic therapy diode laser single session for non-melanoma skin cancer","volume":"6","author":"Souza","year":"2009","journal-title":"Photodiagn. Photodyn. Ther."},{"issue":"5","key":"10.1016\/j.pdpdt.2025.104649_bib0061","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2340\/00015555-0129","article-title":"Topical 5-aminolevulinic acid mediated photodynamic therapy of superficial basal cell carcinoma using two light fractions with a two-hour interval: long-term follow-up","volume":"86","author":"Star","year":"2006","journal-title":"Acta Derm. Venereol."},{"issue":"1","key":"10.1016\/j.pdpdt.2025.104649_bib0062","first-page":"32","article-title":"5-aminolevulinic acid based photodynamic therapy for basal cell carcinoma: a 10-years follow-up study","volume":"15","author":"Gri\u0161kjans","year":"2013","journal-title":"Stomatologija"},{"issue":"1\u20132","key":"10.1016\/j.pdpdt.2025.104649_bib0063","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1615\/JEnvironPatholToxicolOncol.v25.i1-2.260","article-title":"Photodynamic therapy of nodular basal cell carcinoma with multifiber contact light delivery","volume":"25","author":"Thompson","year":"2006","journal-title":"J. Environ. Pathol. Toxicol. Oncol."},{"issue":"4","key":"10.1016\/j.pdpdt.2025.104649_bib0064","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S1572-1000(04)00069-9","article-title":"Photodynamic therapy (PDT) using topically applied delta-aminolevulinic acid (ALA) for the treatment of malignant skin tumors","volume":"1","author":"Sieron","year":"2004","journal-title":"Photodiagn. Photodyn. Ther."},{"issue":"2","key":"10.1016\/j.pdpdt.2025.104649_bib0065","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/lsm.22118","article-title":"A retrospective review of pain control by a two-step irradiance schedule during topical ALA-photodynamic therapy of non-melanoma skin cancer","volume":"45","author":"Zeitouni","year":"2013","journal-title":"Lasers Surg. Med."},{"issue":"12","key":"10.1016\/j.pdpdt.2025.104649_bib0066","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1097\/DSS.0000000000000183","article-title":"A prospective study of pain control by a 2-step irradiance schedule during topical photodynamic therapy of nonmelanoma skin cancer","volume":"40","author":"Zeitouni","year":"2014","journal-title":"Dermatol. Surg."},{"issue":"6","key":"10.1016\/j.pdpdt.2025.104649_bib0067","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1046\/j.1365-2230.2002.01065.x","article-title":"Pain caused by photodynamic therapy of skin cancer","volume":"27","author":"Grapengiesser","year":"2002","journal-title":"Clin. Exp. Dermatol."},{"issue":"6","key":"10.1016\/j.pdpdt.2025.104649_bib0068","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1468-3083.2006.01574.x","article-title":"Our PDT experience in the treatment of non-melanoma skin cancer over the last 7 years","volume":"20","author":"Baptista","year":"2006","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"8","key":"10.1016\/j.pdpdt.2025.104649_bib0069","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1039\/b823378k","article-title":"Topical photodynamic therapy with porphyrin precursors\u2013assessment of treatment-associated pain in a retrospective study","volume":"8","author":"Steinbauer","year":"2009","journal-title":"Photochem. Photobiol. Sci."},{"key":"10.1016\/j.pdpdt.2025.104649_bib0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2020.101980","article-title":"Photodynamic therapy as an alternative treatment in patients with invasive cutaneous SCC where surgery is not feasible: single center experience","volume":"32","author":"Zhang","year":"2020","journal-title":"Photodiagn. Photodyn. Ther."},{"issue":"2","key":"10.1016\/j.pdpdt.2025.104649_bib0071","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.pdpdt.2014.02.006","article-title":"Efficacy of topical ALA-PDT combined with excision in the treatment of skin malignant tumor","volume":"11","author":"Lu","year":"2014","journal-title":"Photodiagn. Photodyn. Ther."},{"issue":"7","key":"10.1016\/j.pdpdt.2025.104649_bib0072","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1524-4725.1998.tb04240.x","article-title":"Modified topical photodynamic therapy of superficial skin tumors, utilizing aminolevulinic acid, penetration enhancers, red light, and hyperthermia","volume":"24","author":"Harth","year":"1998","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.pdpdt.2025.104649_bib0073","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2020.101710","article-title":"Efficacy and safety of 5-aminolevulinic acid photodynamic therapy for the treatment of ulcerative squamous cell carcinoma","volume":"30","author":"Dong","year":"2020","journal-title":"Photodiagn. Photodyn. Ther."},{"issue":"8","key":"10.1016\/j.pdpdt.2025.104649_bib0074","first-page":"1141","article-title":"Evaluation of photodynamic therapy of skin cancers with partial differential alpha-aminolevulinic acid","volume":"115","author":"Xu","year":"2002","journal-title":"Chin. Med. J. (Engl.)"},{"key":"10.1016\/j.pdpdt.2025.104649_bib0075","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.12659\/MSM.900420","article-title":"A clinical trial using attrition combined with 5-aminolevulinic acids based photodynamic therapy in treating squamous cell carcinoma","volume":"23","author":"Peng","year":"2017","journal-title":"Med. Sci. Monit."},{"issue":"3","key":"10.1016\/j.pdpdt.2025.104649_bib0076","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1572-1000(04)00048-1","article-title":"Photodynamic therapy for Bowen's disease and squamous cell carcinoma of the skin","volume":"1","author":"Haddad","year":"2004","journal-title":"Photodiagn. Photodyn. Ther."},{"issue":"5","key":"10.1016\/j.pdpdt.2025.104649_bib0077","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1524-4725.2009.01384.x","article-title":"Reduction in the incidence of squamous cell carcinoma in solid organ transplant recipients treated with cyclic photodynamic therapy","volume":"36","author":"Willey","year":"2010","journal-title":"Dermatol. Surg."},{"issue":"3","key":"10.1016\/j.pdpdt.2025.104649_bib0078","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/jdv.13558","article-title":"Aminolevulinic acid and methyl aminolevulinate equally effective in topical photodynamic therapy for non-melanoma skin cancers","volume":"30","author":"Tarstedt","year":"2016","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"5","key":"10.1016\/j.pdpdt.2025.104649_bib0079","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1046\/j.1365-2133.1996.d01-1076.x","article-title":"Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease","volume":"135","author":"Morton","year":"1996","journal-title":"Br. J. Dermatol."},{"issue":"3","key":"10.1016\/j.pdpdt.2025.104649_bib0080","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1046\/j.1365-2133.2003.05033.x","article-title":"Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen's disease","volume":"148","author":"Salim","year":"2003","journal-title":"Br. J. Dermatol."},{"issue":"2","key":"10.1016\/j.pdpdt.2025.104649_bib0081","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1365-2133.1995.tb02630.x","article-title":"Photodynamic therapy of epithelial skin tumours using delta-aminolaevulinic acid and desferrioxamine","volume":"133","author":"Fijan","year":"1995","journal-title":"Br. J. Dermatol."},{"issue":"4","key":"10.1016\/j.pdpdt.2025.104649_bib0082","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1046\/j.1365-2133.2000.03773.x","article-title":"Comparison of red and green light in the treatment of Bowen's disease by photodynamic therapy","volume":"143","author":"Morton","year":"2000","journal-title":"Br. J. Dermatol."},{"issue":"9","key":"10.1016\/j.pdpdt.2025.104649_bib0083","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1111\/jocd.15886","article-title":"Evaluating the safety and efficacy of aminolevulinic acid 20% topical solution activated by pulsed dye laser and blue light in the treatment of facial cutaneous squamous cell carcinoma in situ","volume":"22","author":"Nestor","year":"2023","journal-title":"J. Cosmet. Dermatol."},{"issue":"4","key":"10.1016\/j.pdpdt.2025.104649_bib0084","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/j.1365-2133.2005.06830.x","article-title":"Investigation of the use of the pulsed dye laser in the treatment of Bowen's disease using 5-aminolaevulinic acid phototherapy","volume":"153","author":"Britton","year":"2005","journal-title":"Br. J. Dermatol."},{"issue":"5","key":"10.1016\/j.pdpdt.2025.104649_bib0085","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.jaad.2019.10.079","article-title":"Photodynamic therapy for cutaneous squamous cell carcinoma in situ: impact of anatomic location, tumor diameter, and incubation time on effectiveness","volume":"82","author":"Kibbi","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"issue":"3","key":"10.1016\/j.pdpdt.2025.104649_bib0086","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/bjc.1994.112","article-title":"Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer","volume":"69","author":"Cairnduff","year":"1994","journal-title":"Br. J. Cancer"},{"issue":"12","key":"10.1016\/j.pdpdt.2025.104649_bib0087","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1097\/DSS.0000000000001608","article-title":"Enhancement of photodynamic therapy for Bowen\u2019s disease using plum-blossom needling to augment drug delivery","volume":"44","author":"Wu","year":"2018","journal-title":"Dermatol. Surg."},{"issue":"10","key":"10.1016\/j.pdpdt.2025.104649_bib0088","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1093\/ced\/llae139","article-title":"Real-world data of 5-aminolaevulinic acid-mediated photodynamic therapy for Bowen disease: a 10-year retrospective study in patients with darker-coloured skin (2011-2021)","volume":"49","author":"Fang","year":"2024","journal-title":"Clin. Exp. Dermatol."},{"issue":"5","key":"10.1016\/j.pdpdt.2025.104649_bib0089","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1007\/s10103-015-1754-1","article-title":"Photodynamic therapy in combination with CO2 laser for the treatment of Bowen's disease","volume":"30","author":"Cai","year":"2015","journal-title":"Lasers Med. Sci."},{"key":"10.1016\/j.pdpdt.2025.104649_bib0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2022.103211","article-title":"Long-term follow up of ALA 10% gel and red-light photodynamic therapy for the treatment of squamous cell carcinoma in situ","volume":"41","author":"Shim","year":"2023","journal-title":"Photodiagn. Photodyn. Ther."},{"issue":"3","key":"10.1016\/j.pdpdt.2025.104649_bib0091","first-page":"319","article-title":"Photodynamic therapy for large or multiple patches of Bowen disease and basal cell carcinoma","volume":"137","author":"Morton","year":"2001","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.pdpdt.2025.104649_bib0092","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2021.102358","article-title":"Photodynamic therapy utilizing 10% ALA nano-emulsion gel and red-light for the treatment of squamous cell carcinoma in-situ on the trunk and extremities: pilot study and literature update","volume":"35","author":"Cervantes","year":"2021","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"10.1016\/j.pdpdt.2025.104649_bib0093","unstructured":"Study to evaluate the safety and efficacy of BF-200 ALA (Ameluz\u24c7) and BF-RhodoLED\u24c7 in the treatment of superficial basal cell carcinoma (sBCC) with photodynamic therapy (PDT). ClinicalTrials.gov identifier: NCT03573401. Updated June 26, 2024. Accessed March 5, 2025. https:\/\/clinicaltrials.gov\/study\/NCT03573401."},{"issue":"2","key":"10.1016\/j.pdpdt.2025.104649_bib0094","first-page":"309","article-title":"A randomized, multinational, noninferiority, phase III trial to evaluate the safety and efficacy of BF-200 aminolaevulinic acid gel vs. methyl aminolaevulinate cream in the treatment of nonaggressive basal cell carcinoma with photodynamic therapy","volume":"179","author":"Morton","year":"2018","journal-title":"Br. J. Dermatol."},{"issue":"5","key":"10.1016\/j.pdpdt.2025.104649_bib0095","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.jaad.2015.12.009","article-title":"Two-fold illumination in topical 5-aminolevulinic acid (ALA)-mediated photodynamic therapy (PDT) for superficial basal cell carcinoma (sBCC): a retrospective case series and cohort study","volume":"74","author":"Kessels","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"issue":"3","key":"10.1016\/j.pdpdt.2025.104649_bib0096","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.pdpdt.2007.04.004","article-title":"Comparison of aminolevulinic acid (ALA)-thermogel-PDT with methyl-ALA-thermogel-PDT in basal cell carcinoma","volume":"4","author":"Schleier","year":"2007","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"10.1016\/j.pdpdt.2025.104649_bib0097","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.pdpdt.2019.03.018","article-title":"Treatment of superficial basal cell carcinoma with photodynamic therapy. Observational study in 22 patients with 5-aminolaevulinic acid and methyl aminolaevulinate","volume":"26","author":"Alique-Garc\u00eda","year":"2019","journal-title":"Photodiagn. Photodyn. Ther."},{"issue":"12","key":"10.1016\/j.pdpdt.2025.104649_bib0098","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1111\/j.1468-3083.2010.03670.x","article-title":"Pain during topical photodynamic therapy: uncomfortable and unpredictable","volume":"24","author":"Arits","year":"2010","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"1","key":"10.1016\/j.pdpdt.2025.104649_bib0099","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1346-8138.2000.tb02109.x","article-title":"Repeated 5-aminolevulinic acid-based photodynamic therapy following electro-curettage for pigmented basal cell carcinoma","volume":"27","author":"Itoh","year":"2000","journal-title":"J. Dermatol."},{"issue":"6","key":"10.1016\/j.pdpdt.2025.104649_bib0100","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1111\/j.1365-2133.2012.10878.x","article-title":"High and sustained efficacy after two sessions of topical 5-aminolaevulinic acid photodynamic therapy for basal cell carcinoma: a prospective, clinical and histological 10-year follow-up study","volume":"166","author":"Christensen","year":"2012","journal-title":"Br. J. Dermatol."},{"issue":"1","key":"10.1016\/j.pdpdt.2025.104649_bib0101","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1468-3083.2008.02946.x","article-title":"Photodynamic therapy with 5-aminolaevulinic acid, dimethylsulfoxide and curettage in basal cell carcinoma: a 6-year clinical and histological follow-up","volume":"23","author":"Christensen","year":"2009","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"5","key":"10.1016\/j.pdpdt.2025.104649_bib0102","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1080\/028418600750013285","article-title":"Photodynamic therapy of residual or recurrent basal cell carcinoma after radiotherapy using topical 5-aminolevulinic acid or methylester aminolevulinic acid","volume":"39","author":"Soler","year":"2000","journal-title":"Acta Oncol."},{"issue":"3","key":"10.1016\/j.pdpdt.2025.104649_bib0103","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1080\/000155599750010977","article-title":"Photodynamic therapy by topical aminolevulinic acid, dimethylsulphoxide and curettage in nodular basal cell carcinoma: a one-year follow-up study","volume":"79","author":"Soler","year":"1999","journal-title":"Acta Derm. Venereol."},{"issue":"1","key":"10.1016\/j.pdpdt.2025.104649_bib0104","doi-asserted-by":"crossref","first-page":"94","DOI":"10.26444\/aaem\/183059","article-title":"Efficacy of photodynamic therapy using ALAHCl in gel with a lipid nanoemulsion and MALHCl in cream in superficial basal cell carcinoma","volume":"31","author":"Szczepanik-Ku\u0142ak","year":"2024","journal-title":"Ann. Agric. Environ. Med."},{"key":"10.1016\/j.pdpdt.2025.104649_bib0105","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.pdpdt.2019.06.016","article-title":"Ocular preservation through limited tumor excision combined with ALA-PDT in patients with periocular basal cell carcinoma","volume":"27","author":"Li","year":"2019","journal-title":"Photodiagn. Photodyn. Ther."},{"issue":"4","key":"10.1016\/j.pdpdt.2025.104649_bib0106","doi-asserted-by":"crossref","first-page":"327","DOI":"10.4103\/0019-5154.113968","article-title":"Aminolevulinic acid-photodynamic therapy of basal cell carcinoma and factors affecting the response to treatment: a clinical trial","volume":"58","author":"Tehranchinia","year":"2013","journal-title":"Indian J. Dermatol."},{"key":"10.1016\/j.pdpdt.2025.104649_bib0107","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.pdpdt.2019.08.011","article-title":"Treatment of Bowen's disease with photodynamic therapy. Observational study in 171 patients with 5-aminolaevulinic acid (BF-200 ALA) and methyl aminolaevulinate (MAL)","volume":"28","author":"Alique-Garc\u00eda","year":"2019","journal-title":"Photodiagn. Photodyn. Ther."}],"container-title":["Photodiagnosis and Photodynamic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1572100025001814?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1572100025001814?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T08:18:37Z","timestamp":1756714717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1572100025001814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":107,"alternative-id":["S1572100025001814"],"URL":"https:\/\/doi.org\/10.1016\/j.pdpdt.2025.104649","relation":{},"ISSN":["1572-1000"],"issn-type":[{"value":"1572-1000","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"5-aminolevulinic acid photodynamic therapy for the treatment of basal and squamous cell carcinoma: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Photodiagnosis and Photodynamic Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pdpdt.2025.104649","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104649"}}